Bristol Myers Squibb (BMS) has entered into an agreement with Cellares to bolster the manufacturing of chimeric antigen receptor (CAR) T cell therapies.
Cellares Announces Expanded Agreement with Bristol Myers Squibb to Include Second CAR-T Program in Cellares' Technology Adoption Partnership Program finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Bristol-Myers Squibb (BMY) and Cellares Enter Expanded Agreement to Include Second CAR-T Program in Cellares' Technology Adoption Partnership Program streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cellares, Bristol Myers Squibb expand manufacturing agreement njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.